glp-1 agonists gastrointestinal side effects constipation diarrhea Clinical Recommendations to Manage Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus ๐ DID YOU KNOW? GLP-1
Description
Attorneys reviewing claims involving once-weekly semaglutide medications typically analyze prescription history, ophthalmology records, diagnostic testing, and treatment timelines when evaluating potential cases
[DOI] [PubMed] [Google Scholar] [8].Marrano N, Biondi G, Borrelli A, Cignarelli A, Perrini S, Laviola L, et al

doi: 10.1016/0014-5793(88)80821-4

Yes-Zepbound and Mounjaro contain the same active ingredient (tirzepatide) but are FDA approved for different conditions: Zepbound for weight management and Mounjaro for type 2 diabetes

The goal is to find the lowest effective dose that works for you
